Institutional investors purchased a net $486.3 thousand shares of NVIV during the quarter ended September 2016, and now own 24.83% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BLACKROCK FUND ADVISORS Bought 165.6 Thousand shares of InVivo Therapeutics Holdi...